Currently, GeneDx Holdings Corp [WGS] is trading at $136.87, down -1.87%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The WGS shares have gain 3.88% over the last week, with a monthly amount glided 13.34%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GeneDx Holdings Corp [NASDAQ: WGS] stock has seen the most recent analyst activity on October 20, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $155. Previously, Piper Sandler started tracking the stock with Overweight rating on July 09, 2025, and set its price target to $110. On May 15, 2025, Guggenheim initiated with a Buy rating and assigned a price target of $88 on the stock. Jefferies upgraded its rating to a Buy but stick to its price target of $80 on May 09, 2025. Wells Fargo initiated its recommendation with a Equal Weight and recommended $34 as its price target on August 28, 2024. Craig Hallum started tracking with a Buy rating for this stock on July 10, 2024, and assigned it a price target of $43.
This stock has fluctuated between a low of $55.17 and a high of $146.00 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $153.75 within the next 12 months. GeneDx Holdings Corp [NASDAQ: WGS] shares were valued at $136.87 at the most recent close of the market. An investor can expect a potential return of 12.33% based on the average WGS price forecast.
Analyzing the WGS fundamentals
Trailing Twelve Months sales for GeneDx Holdings Corp [NASDAQ:WGS] were 402.19M which represents 51.86% growth. Gross Profit Margin for this corporation currently stands at 0.7% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.01 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 133.49 points at the first support level, and at 130.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 139.75, and for the 2nd resistance point, it is at 142.64.
Ratios To Look Out For
To put it in perspective, the Current Ratio for GeneDx Holdings Corp [NASDAQ:WGS] is 2.71. Also, the Quick Ratio is 2.59, while the Cash Ratio stands at 1.1. Considering the valuation of this stock, the price to sales ratio is 9.84, the price to book ratio is 13.53 and price to earnings (TTM) ratio is 2269.82.
Transactions by insiders
Recent insider trading involved Stueland Katherine, CHIEF EXECUTIVE OFFICER, that happened on Oct 29 ’25 when 2158.0 shares were sold. CHIEF FINANCIAL OFFICER, Feeley Kevin completed a deal on Oct 29 ’25 to sell 388.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Stueland Katherine sold 12858.0 shares on Sep 30 ’25.
